John Nadeau

2.4k total citations
30 papers, 1.9k citations indexed

About

John Nadeau is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, John Nadeau has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in John Nadeau's work include Blood Pressure and Hypertension Studies (7 papers), Receptor Mechanisms and Signaling (6 papers) and Hormonal Regulation and Hypertension (6 papers). John Nadeau is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Receptor Mechanisms and Signaling (6 papers) and Hormonal Regulation and Hypertension (6 papers). John Nadeau collaborates with scholars based in United States and Canada. John Nadeau's co-authors include Nancy J. Brown, David L. Robertson, Andrew J. Wood, L E Limbird, Douglas E. Vaughan, Ross D. Feldman, James V. Gainer, A. J. J. Wood, David Robertson and David L. Page and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

John Nadeau

30 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Nadeau United States	18	539	530	473	384	317	30	1.9k
Kazuoki Kondo Japan	27	433 0.8×	1.1k 2.1×	503 1.1×	275 0.7×	691 2.2×	120	2.6k
Anastasios Kalofoutis Greece	26	376 0.7×	462 0.9×	297 0.6×	365 1.0×	459 1.4×	58	2.3k
Yukio Miura Japan	23	564 1.0×	712 1.3×	567 1.2×	165 0.4×	440 1.4×	101	2.0k
E Comoy France	24	348 0.6×	361 0.7×	447 0.9×	338 0.9×	450 1.4×	77	2.0k
Kari Kervinen Finland	34	726 1.3×	938 1.8×	1.2k 2.6×	1.0k 2.7×	519 1.6×	82	3.5k
Carlos P. Vío Chile	30	628 1.2×	501 0.9×	380 0.8×	354 0.9×	1.2k 3.7×	99	2.9k
Chiaki Shigemasa Japan	28	752 1.4×	622 1.2×	410 0.9×	245 0.6×	644 2.0×	138	2.4k
David Casley Australia	31	1.5k 2.7×	775 1.5×	239 0.5×	786 2.0×	937 3.0×	88	2.9k
Adviye Ergul United States	29	787 1.5×	318 0.6×	240 0.5×	940 2.4×	714 2.3×	83	2.8k
William M. Manger United States	23	343 0.6×	912 1.7×	1.0k 2.2×	182 0.5×	236 0.7×	61	1.9k

Countries citing papers authored by John Nadeau

Since Specialization

Citations

This map shows the geographic impact of John Nadeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Nadeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Nadeau more than expected).

Fields of papers citing papers by John Nadeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Nadeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Nadeau. The network helps show where John Nadeau may publish in the future.

Co-authorship network of co-authors of John Nadeau

This figure shows the co-authorship network connecting the top 25 collaborators of John Nadeau. A scholar is included among the top collaborators of John Nadeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Nadeau. John Nadeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrd, James Brian, Saba Sile, James V. Gainer, et al.. (2007). Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema. Hypertension. 51(1). 141–147. 114 indexed citations

Blevins, Lewis S., et al.. (2002). Hypertension in an Adolescent Boy. The American Journal of the Medical Sciences. 323(4). 227–230. 2 indexed citations

Brown, Nancy J., Kyung‐Soo Kim, Yan Chen, et al.. (2000). Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production1. The Journal of Clinical Endocrinology & Metabolism. 85(1). 336–344. 156 indexed citations

Goldstein, Richard E., James A. O’Neill, George Holcomb, et al.. (1999). Clinical Experience Over 48 Years With Pheochromocytoma. Annals of Surgery. 229(6). 755–755. 316 indexed citations

Gainer, James V., Tracy E. Hunley, Valentina Kon, et al.. (1997). Angiotensin II type I Receptor polymorphism in African Americans lower frequency of the C1166 variant. IUBMB Life. 43(1). 227–231. 13 indexed citations

Brown, Nancy J., et al.. (1996). Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 703–712. 31 indexed citations

Gainer, James V., et al.. (1996). Increased sensitivity to bradykinin among African Americans. Journal of Allergy and Clinical Immunology. 98(2). 283–287. 72 indexed citations

Daniel, Vincent C., et al.. (1994). Simplified assay for the quantification of 2,3-dinor-6-ketoprostaglandin F1α by gas chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 653(2). 117–122. 43 indexed citations

Brown, Nancy J., et al.. (1993). Caffeine attenuates the renal vascular response to angiotensin II infusion.. Hypertension. 22(6). 847–852. 16 indexed citations

10.

Schwartz, Alan R., Norman Schubert, Bernard R. Marsh, et al.. (1992). Effect of Uvulopalatopharyngoplasty on Upper Airway Collapsibility in Obstructive Sleep Apnea. American Review of Respiratory Disease. 145(3). 527–532. 133 indexed citations

11.

Houston, Mark C., et al.. (1990). The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension. American Heart Journal. 120(1). 172–179. 8 indexed citations

12.

Naslund, Thomas C., et al.. (1990). Low sodium intake corrects abnormality in β-receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β-receptor function in vitro. Clinical Pharmacology & Therapeutics. 48(1). 87–95. 53 indexed citations

13.

Toogood, J.H., et al.. (1988). Effect of High-dose Inhaled Budesonide on Calcium and Phosphate Metabolism and the Risk of Osteoporosis. American Review of Respiratory Disease. 138(1). 57–61. 53 indexed citations

14.

Naslund, Thomas C., et al.. (1988). α-Adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect. Clinical Pharmacology & Therapeutics. 44(6). 699–703. 7 indexed citations

15.

Roden, Dan M., John Nadeau, & R.Kirby Primm. (1988). Electrophysiologic and hemodynamic effects of chronic oral therapy with the α2-agonists clonidine and tiamenidine in hypertensive volunteers. Clinical Pharmacology & Therapeutics. 43(6). 648–654. 4 indexed citations

16.

Hollister, Alan S., et al.. (1986). Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.. Journal of Clinical Investigation. 77(5). 1416–1421. 43 indexed citations

17.

Dean, Richard H., et al.. (1984). Aortic and Renal Vascular Disease. Annals of Surgery. 200(3). 336–344. 49 indexed citations

18.

Ogilvie, Richard I., et al.. (1982). Diazoxide concentration-response relation in hypertension.. Hypertension. 4(1). 167–173. 9 indexed citations

19.

Ogilvie, Richard I., et al.. (1982). Vasodilator Capacity of Forearm Vessels in Hypertension. Clinical and Experimental Hypertension Part A Theory and Practice. 4(8). 1391–1407. 6 indexed citations

20.

Ogilvie, Richard I. & John Nadeau. (1982). Cardiovascular effects of acebutolol and hydrochlorothiazide in essential hypertension.. Hypertension. 4(2). 320–324. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact